sunitinib malate — Medica
Differentiated thyroid carcinoma (papillary, follicular, oncocytic/Hürthle cell)
Initial criteria
- age ≥ 18 years
- Patient has papillary or follicular thyroid carcinoma that is refractory to radioactive iodine therapy OR has oncocytic (formerly Hürthle cell) carcinoma
Approval duration
1 year